<VariationArchive RecordType="classified" VariationID="1805571" VariationName="NM_001197104.2(KMT2A):c.11073dup (p.Ala3692fs)" VariationType="Duplication" Accession="VCV001805571" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-24" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1862582" VariationID="1805571">
      <GeneList>
        <Gene Symbol="KMT2A" FullName="lysine methyltransferase 2A" GeneID="4297" HGNC_ID="HGNC:7132" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="118436492" stop="118526832" display_start="118436492" display_stop="118526832" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118307204" stop="118397538" display_start="118307204" display_stop="118397538" Strand="+" />
          </Location>
          <OMIM>159555</OMIM>
          <Haploinsufficiency last_evaluated="2018-05-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-05-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2A">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="TTC36-AS1" FullName="TTC36 and KMT2A antisense RNA 1" GeneID="101929089" HGNC_ID="HGNC:55495" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="118511918" stop="118531094" display_start="118511918" display_stop="118531094" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001197104.2(KMT2A):c.11073dup (p.Ala3692fs)</Name>
      <CanonicalSPDI>NC_000011.10:118511951:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="118511951" stop="118511952" display_start="118511951" display_stop="118511952" variantLength="1" positionVCF="118511951" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118382666" stop="118382667" display_start="118382666" display_stop="118382667" variantLength="1" positionVCF="118382666" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>A3689fs</ProteinChange>
      <ProteinChange>A3692fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001197104.1" sequenceAccession="NM_001197104" sequenceVersion="1" change="c.11073dupT">
            <Expression>NM_001197104.1:c.11073dupT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_613" sequenceAccession="LRG_613">
            <Expression>LRG_613:g.80463dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_613t1" sequenceAccession="LRG_613t1">
            <Expression>LRG_613t1:c.11073dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_613p1" sequenceAccession="LRG_613p1" change="p.Ala3692Cysfs">
            <Expression>LRG_613p1:p.Ala3692Cysfs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.118511952dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.118511952dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.118382667dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.118382667dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027813.1" sequenceAccession="NG_027813" sequenceVersion="1" change="g.80463dup">
            <Expression>NG_027813.1:g.80463dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_120574.1" sequenceAccession="NR_120574" sequenceVersion="1" change="n.470dup">
            <Expression>NR_120574.1:n.470dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001197104.2" sequenceAccession="NM_001197104" sequenceVersion="2" change="c.11073dup" MANESelect="true">
            <Expression>NM_001197104.2:c.11073dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001184033.1" sequenceAccession="NP_001184033" sequenceVersion="1" change="p.Ala3692fs">
            <Expression>NP_001184033.1:p.Ala3692fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001412597.1" sequenceAccession="NM_001412597" sequenceVersion="1" change="c.11163dup">
            <Expression>NM_001412597.1:c.11163dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001399526.1" sequenceAccession="NP_001399526" sequenceVersion="1" change="p.Ala3722Cysfs">
            <Expression>NP_001399526.1:p.Ala3722Cysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005933.4" sequenceAccession="NM_005933" sequenceVersion="4" change="c.11064dup">
            <Expression>NM_005933.4:c.11064dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005924.2" sequenceAccession="NP_005924" sequenceVersion="2" change="p.Ala3689fs">
            <Expression>NP_005924.2:p.Ala3689fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001197104.2(KMT2A):c.11073dup (p.Ala3692fs) AND Wiedemann-Steiner syndrome" Accession="RCV002471989" Version="1">
        <ClassifiedConditionList TraitSetID="8851">
          <ClassifiedCondition DB="MedGen" ID="C1854630">Wiedemann-Steiner syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-05-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-05-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="8851" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5217" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Wiedemann-Steiner syndrome</ElementValue>
                <XRef ID="MONDO:0011518" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Growth deficiency and mental retardation with facial dysmorphism</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">WDSTS</ElementValue>
                <XRef Type="MIM" ID="605130" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5565" />
                <XRef ID="5565" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Wiedemann-Steiner syndrome (WSS) is characterized by developmental delay, intellectual disability, and characteristic facial features, with or without additional congenital anomalies. The facial features include thick eyebrows with lateral flare, vertically narrow and downslanted palpebral fissures, widely spaced eyes, long eyelashes, wide nasal bridge, broad nasal tip, thin vermilion of the upper lip, and thick scalp hair. About 60% of affected individuals have hypertrichosis cubiti ("hairy elbows"), which was once thought to be pathognomic for the syndrome, with a majority having hypertrichosis of other body parts. Other clinical features include feeding difficulties, prenatal and postnatal growth restriction, epilepsy, ophthalmologic anomalies, congenital heart defects, hand anomalies (such as brachydactyly and clinodactyly), hypotonia, vertebral anomalies (especially fusion anomalies of the cervical spine), renal and uterine anomalies, immune dysfunction, brain malformations, and dental anomalies.</Attribute>
                <XRef ID="NBK580718" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35617449</ID>
                <ID Source="BookShelf">NBK580718</ID>
              </Citation>
              <XRef ID="319182" DB="Orphanet" />
              <XRef ID="C1854630" DB="MedGen" />
              <XRef ID="MONDO:0011518" DB="MONDO" />
              <XRef Type="MIM" ID="605130" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5414017" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_001197104_1_KMT2A_c_11073dupT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002767696" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-05-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0107 - This gene is known to be associated with autosomal dominant disease. (N) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (exon 31 of 36). (P) 0251 - Variant is heterozygous. (N) 0301 - Variant is absent from gnomAD. (P) 0701 - Comparable NMD causing variants have very strong previous evidence for pathogenicity (ClinVar). (P) 0807 - Variant has not previously been reported in a clinical context. (N) 0905 - No segregation evidence has been identified for this variant. (N) 1007 - No published functional evidence has been identified for this variant. (N) 1102 - Strong phenotype match. (P) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_2569</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001197104.1:c.11073dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0011518" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5414017" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0011518" MappingRef="MONDO">
        <MedGen CUI="C1854630" Name="Wiedemann-Steiner syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

